Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 15/20 | 0.65 |
| ▸ | HSP90AB1 | P08238 | 14/20 | 0.65 |
| ▸ | TRAP1 | Q12931 | 5/20 | 0.65 |
| ▸ | HSP90B1 | P14625 | 2/20 | 0.65 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.65 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.59 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.59 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.59 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.59 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21130154 | 0.92 | HSP90AA1 (0.54) | HSP90AA1HSP90AB1TRAP1HSP90B1ERBB2 | |
| SCHEMBL18417663 | 0.91 | HSP90AA1 (0.54) | HSP90AA1HSP90AB1TRAP1HSP90B1ERBB2 | |
| SCHEMBL17080306 | 0.90 | HSP90AA1 (0.69) | HSP90AA1HSP90AB1TRAP1HSP90B1ERBB2 | |
| SCHEMBL16569779 | 0.88 | HSP90AA1 (0.67) | HSP90AA1HSP90AB1TRAP1HSP90B1ERBB2 | |
| SCHEMBL21889014 | 0.88 | HSP90AA1 (0.62) | HSP90AA1HSP90AB1TRAP1HSP90B1ERBB2 | |
| SCHEMBL3464858 | 0.88 | HSP90AA1 (0.49) | HSP90AA1HSP90AB1TRAP1HSP90B1ERBB2 | |
| SCHEMBL18460273 | 0.88 | HSP90AA1 (0.49) | HSP90AA1HSP90AB1TRAP1HSP90B1ERBB2 | |
| SCHEMBL15980563 | 0.86 | HSP90AB1 (0.60) | HSP90AA1HSP90AB1TRAP1HSP90B1ERBB2 | |
| SCHEMBL3464842 | 0.86 | HSP90AB1 (0.49) | HSP90AA1HSP90AB1TRAP1HSP90B1ERBB2 | |
| SCHEMBL16569684 | 0.86 | HSP90AA1 (0.68) | HSP90AA1HSP90AB1TRAP1HSP90B1ERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3086792-B1 | METHODS AND REAGENTS FOR RADIOLABELING | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2022-10-12 | — | — | EP | disclosed |
| US-10793570-B2 | Methods and reagents for radiolabeling | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2020-10-06 | — | — | US | disclosed |
| US-20200017502-A1 | METHODS AND REAGENTS FOR RADIOLABELING | MEMORIAL SLOAN-KETTERING CANCER CENTER | 2020-01-16 | — | — | US | disclosed |
| US-10329293-B2 | Methods and reagents for radiolabeling | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2019-06-25 | — | — | US | disclosed |
| US-9994573-B2 | Methods and reagents for radiolabeling | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2018-06-12 | — | — | US | disclosed |
| US-9994573-B2 | Methods and reagents for radiolabeling | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2018-06-12 | — | — | US | disclosed |
| US-20170029426-A1 | METHODS AND REAGENTS FOR RADIOLABELING | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2017-02-02 | — | — | US | disclosed |
| US-20170029426-A1 | METHODS AND REAGENTS FOR RADIOLABELING | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2017-02-02 | — | — | US | disclosed |
| WO-2015138039-A1 | METHODS AND REAGENTS FOR RADIOLABELING | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2015-09-17 | — | — | WO | disclosed |
| US-20100240656-A1 | COMPOUNDS AS HSP90 INHIBITORS | ORYZON GENOMICS, S.A. (ES) | 2010-09-23 | — | — | US | disclosed |
| EP-2183221-A1 | NEW COMPOUNDS AS HSP90 INHIBITORS | Crystax Pharmaceuticals S.L. (ES) | 2010-05-12 | — | — | EP | disclosed |
| WO-2009007399-A1 | NEW COMPOUNDS AS HSP90 INHIBITORS | CRYSTAX PHARMACEUTICALS, S.L. (ES) | 2009-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10793570-B2 | Methods and reagents for radiolabeling | HSP90AB1, HSP90B1, HSP90AA1 | HSP90AA1 3/4885HSP90AB1 1/4885TRAP1 6/4885 |
| US-20170029426-A1 | METHODS AND REAGENTS FOR RADIOLABELING | HSP90AB1, HSP90B1, HSP90AA1 | HSP90AA1 3/4885HSP90AB1 1/4885TRAP1 6/4885 |
| US-10329293-B2 | Methods and reagents for radiolabeling | HSP90AB1, HSP90B1, HSP90AA1 | HSP90AA1 3/4885HSP90AB1 1/4885TRAP1 6/4885 |
| US-20200017502-A1 | METHODS AND REAGENTS FOR RADIOLABELING | HSP90AB1, HSP90B1, HSP90AA1 | HSP90AA1 3/4885HSP90AB1 1/4885TRAP1 6/4885 |
| US-20100240656-A1 | COMPOUNDS AS HSP90 INHIBITORS | HSP90AB1, HSP90AB2P, HSP90AA1 | HSP90AA1 3/4885HSP90AB1 1/4885TRAP1 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.